Copyright
©2013 Baishideng Publishing Group Co., Limited. All rights reserved.
World J Clin Cases. Aug 16, 2013; 1(5): 169-171
Published online Aug 16, 2013. doi: 10.12998/wjcc.v1.i5.169
Published online Aug 16, 2013. doi: 10.12998/wjcc.v1.i5.169
Hypoglycemia associated with fluoxetine treatment in a patient with type 1 diabetes
Betina Biagetti, Rosa Corcoy, Servei d’Endocrinologia i Nutrició, Hospital de la Santa Creu i Sant Pau, Avgda Sant Antoni M Claret 167, 08025 Barcelona, Spain
Rosa Corcoy, Department de Medicina, Universitat Autònoma de Barcelona, 08193 Belllaterra, Spain
Rosa Corcoy, CIBER Bioengineering, Biomaterials and Nanotechnology, Instituto de Salud Carlos III, 28029 Madrid, Spain
Author contributions: Biagetti B and Corcoy R were the attending physicians; Corcoy R designed the report; Biagetti B wrote the document.
Correspondence to: Rosa Corcoy, MD, PhD, Servei d’Endocrinologia i Nutrició, Hospital de la Santa Creu i Sant Pau, Avgda Sant Antoni M Claret 167, 08025 Barcelona, Spain. rcorcoy@santpau.cat
Telephone: +34-93-5565661 Fax: +34-93-5565602
Received: May 15, 2013
Revised: June 20, 2013
Accepted: July 4, 2013
Published online: August 16, 2013
Revised: June 20, 2013
Accepted: July 4, 2013
Published online: August 16, 2013
Core Tip
Core tip: A patient with type 1 diabetes mellitus presented with hypoglycemia and a marked reduction in insulin requirements associated with fluoxetine treatment. Hypoglycemia accompanying treatment with fluoxetine has been reported in patients with type 1 or type 2 diabetes mellitus. Healthcare professionals should be aware of this association for the sake of patient safety.